Skip to search
Skip to main content
Back to Search
Start Over
GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - AN INTERIM ANALYSIS
Authors :
Schuster, S. J. Bishop, M. R. Tam, C. Waller, E. K. Borchmann, P. McGuirk, J. Jaeger, U. Jaglowski, S. Andreadis, C. Westin, J. Fleury, I. Bachanova, V. Foley, S. R. Ho, P. J. Mielke, S. Magenau, J. M. Holte, H. Anak, O. Pacaud, L. Awasthi, R. Tai, F. Salles, G. Maziarz, R. T. Schuster, S. J. Bishop, M. R. Tam, C. Waller, E. K. Borchmann, P. McGuirk, J. Jaeger, U. Jaglowski, S. Andreadis, C. Westin, J. Fleury, I. Bachanova, V. Foley, S. R. Ho, P. J. Mielke, S. Magenau, J. M. Holte, H. Anak, O. Pacaud, L. Awasthi, R. Tai, F. Salles, G. Maziarz, R. T.
Publication Year :
2017
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1201323228
Document Type :
Electronic Resource